INFERCARE Trademark

Trademark Overview


On Thursday, October 21, 2021, a trademark application was filed for INFERCARE with the United States Patent and Trademark Office. The USPTO has given the INFERCARE trademark a serial number of 97086685. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, September 14, 2023. This trademark is owned by Infervision Medical Technology Co., Ltd.. The INFERCARE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Design, installation, updating and maintenance of computer software; Medical research services; Platform as a service (PAAS) featuring computer software platforms for managing data for use in clinical application and medical analysis; Providing medical and scientific research information in the field of clinical trials; Rental of computer software; Software as a service (SAAS) services featuring software for analyzing and reporting self-assessment of illness; Technical consulting in the field of artificial intelligence (AI) software customization; Technological research in the field of artificial Intelligence for healthcare and clinical monitoring, diagnosis, analysis and prediction
infercare

General Information


Serial Number97086685
Word MarkINFERCARE
Filing DateThursday, October 21, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, September 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements


Description of MarkThe mark consists of stylized word InferCare.
Pseudo MarkINFER CARE
Goods and ServicesDesign, installation, updating and maintenance of computer software; Medical research services; Platform as a service (PAAS) featuring computer software platforms for managing data for use in clinical application and medical analysis; Providing medical and scientific research information in the field of clinical trials; Rental of computer software; Software as a service (SAAS) services featuring software for analyzing and reporting self-assessment of illness; Technical consulting in the field of artificial intelligence (AI) software customization; Technological research in the field of artificial Intelligence for healthcare and clinical monitoring, diagnosis, analysis and prediction

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInfervision Medical Technology Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBeijing 100025
CN

Party NameInfervision Medical Technology Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBeijing 100025
CN

Trademark Events


Event DateEvent Description
Saturday, September 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2023SOU EXTENSION 1 GRANTED
Thursday, September 14, 2023SOU EXTENSION 1 FILED
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 5, 2022NON-FINAL ACTION E-MAILED
Tuesday, July 5, 2022NON-FINAL ACTION WRITTEN
Thursday, June 30, 2022ASSIGNED TO EXAMINER
Sunday, November 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 25, 2021NEW APPLICATION ENTERED